TY - JOUR
T1 - The association between loss of Medicare, immunosuppressive medication use, and kidney transplant outcomes
AU - Hart, Allyson
AU - Gustafson, Sally K.
AU - Wey, Andrew
AU - Salkowski, Nicholas
AU - Snyder, Jon J.
AU - Kasiske, Bertram L.
AU - Israni, Ajay K.
N1 - Publisher Copyright:
Published 2019. This article is a U.S. Government work and is in the public domain in the USA
PY - 2019/7
Y1 - 2019/7
N2 - Kidney transplant recipients aged <65 years qualify for Medicare coverage, but coverage ends 3 years posttransplant. We determined the association between timing of Medicare loss and immunosuppressive medication fills and kidney allograft loss. Using data from the Scientific Registry of Transplant Recipients (SRTR), US Renal Data System, and Symphony pharmacy fill database, we analyzed 78 861 Medicare-covered, kidney-alone recipients aged <65 years, and assessed the timing of Medicare loss posttransplant: early (<3 years), on-time (at 3 years), or late (>3 years). Immunosuppressant use was measured as medication possession ratio (MPR). Allograft loss was assessed using SRTR data. MPR was lower for recipients with early or late Medicare loss compared with no coverage loss for all immunosuppressive medication types. For calcineurin inhibitors, early Medicare loss was associated with a 53% to 86% lower MPR. On-time Medicare loss was not associated with a lower MPR. When recipients were matched by age, posttransplant timing of Medicare loss, and donor risk, the hazard of allograft loss was 990% to 1630% higher after early Medicare loss, and 140% to 740% higher after late Medicare loss, with no difference in the hazard for on-time Medicare loss. Ensuring ongoing Medicare access before and after 3 years posttransplant could affect graft survival.
AB - Kidney transplant recipients aged <65 years qualify for Medicare coverage, but coverage ends 3 years posttransplant. We determined the association between timing of Medicare loss and immunosuppressive medication fills and kidney allograft loss. Using data from the Scientific Registry of Transplant Recipients (SRTR), US Renal Data System, and Symphony pharmacy fill database, we analyzed 78 861 Medicare-covered, kidney-alone recipients aged <65 years, and assessed the timing of Medicare loss posttransplant: early (<3 years), on-time (at 3 years), or late (>3 years). Immunosuppressant use was measured as medication possession ratio (MPR). Allograft loss was assessed using SRTR data. MPR was lower for recipients with early or late Medicare loss compared with no coverage loss for all immunosuppressive medication types. For calcineurin inhibitors, early Medicare loss was associated with a 53% to 86% lower MPR. On-time Medicare loss was not associated with a lower MPR. When recipients were matched by age, posttransplant timing of Medicare loss, and donor risk, the hazard of allograft loss was 990% to 1630% higher after early Medicare loss, and 140% to 740% higher after late Medicare loss, with no difference in the hazard for on-time Medicare loss. Ensuring ongoing Medicare access before and after 3 years posttransplant could affect graft survival.
KW - clinical research/practice
KW - insurance - public
KW - kidney transplantation/nephrology
KW - Scientific Registry for Transplant Recipients (SRTR)
UR - http://www.scopus.com/inward/record.url?scp=85062495567&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062495567&partnerID=8YFLogxK
U2 - 10.1111/ajt.15293
DO - 10.1111/ajt.15293
M3 - Article
C2 - 30838768
AN - SCOPUS:85062495567
SN - 1600-6135
VL - 19
SP - 1964
EP - 1971
JO - American Journal of Transplantation
JF - American Journal of Transplantation
IS - 7
ER -